Kate Allardice RN RM (she/her)
Senior Research Nurse – Disease Elimination
Working groups

Background
Kate has a background in sexual health and blood borne viruses, midwifery and clinical research. She has a passion for working with people who may find it difficult to access mainstream healthcare.
Prior to joining Burnet, Kate worked as a nurse and midwife in Indigenous health in Alice Springs. She also worked in sexual health in Lismore, Melbourne and Darwin, and clinical research at the Royal Women’s Hospital in Melbourne and Melbourne Sexual Health Service.
Kate has worked on nurse-led outreach projects to provide hepatitis C testing and treatment to People Who Inject Drugs (PWID) since starting at Burnet. She has been the nursing lead on the PharmEC and QuickStart studies, both of which explore more equitable ways to provide testing and treatment of hepatitis C to PWIDs.
Qualifications
- 1980: Registered Nurse (hospital-based training) Royal Darwin Hospital
- 2006: Graduate Diploma of Midwifery Deakin University and Eastern Health Box Hill Hospital
Positions
- 2022: Senior Research Nurse – Disease Elimination, Burnet Institute
- 2016: Research Nurse – Disease Elimination, Burnet Institute
Burnet publications
View 2 moreBalancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial
Journal of Viral Hepatitis
Katherine Heath et al
Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol
BMJ Open
Joseph Doyle et al
Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial
Alimentary Pharmacology & Therapeutics
Christopher J. Byrne et al
Current projects

EXPAND-C: hepatitis C testing and treatment through community pharmacies
Expanding access to hepatitis C testing and treatment using a pharmacy-based model.

The QuickStart Study
QuickStart aims to increase hepatitis C testing and treatment through rapid point-of-care tests and a same-day test-and-treat model in primary care settings.
Past projects

PharmEC REACH study: reaching methadone users attending community pharmacies with HCV
This project assesses the effectiveness, feasibility and cost-effectiveness of nurse-led testing and treatment of hepatitis C in community pharmacies for people on opiate substitution therapy.

The elimination of hepatitis C as a global public health threat
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.